Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network

Autor: Kahl, B.S. ^*, Longo, W.L., Eickhoff, J.C., Zehnder, J., Jones, C., Blank, J., McFarland, T., Bottner, W., Rezazedeh, H., Werndli, J., Bailey, H.H.

Publikováno v: In Annals of Oncology September 2006 17(9):1418-1423

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.

Autor: Chang JE; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Havighurst T; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Kim K; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Eickhoff J; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, USA., Traynor AM; Department of Medicine, University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Kirby-Slimp R; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Volk LM; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Werndli J; University of Wisconsin School of Medicine and Public Health and the UW Carbone Cancer Center, Madison, WI, USA., Go RS; Gunderson Health System, La Crosse, WI, USA., Weiss M; ThedaCare Cancer Care, Appleton, WI, USA., Blank J; Green Bay Oncology and the Saint Vincent Regional Cancer Center, Green Bay, WI, USA., Kahl BS; Washington University, St. Louis, MO, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (2), pp. 283-91. Date of Electronic Publication: 2016 Feb 23.

Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT

Autor: Larson, G. P., Ding, Y., Cheng, L. S. -C, Lundberg, C., Gagalang, V., Rivas, G., Geller, L., Jeffrey Weitzel, Macdonald, D., Archambeau, J., Slater, J., Neuberg, D., Daly, M. B., Angel, I., Benson Iii, A. B., Smith, K., Kirkwood, J. M., O Dwyer, P. J., Raskay, B., Sutphen, R., Drew, R., Stewart, J. A., Werndli, J., Johnson, D., Ruckdeschel, J. C., Elston, R. C., Krontiris, T. G.

Publikováno v: Scopus-Elsevier

We conducted linkage analysis of 80 candidate genes in 201 brother pairs affected with prostatic adenocarcinoma. Markers representing two adjacent candidate genes on chromosome 3p, CDC25A and FHIT, showed suggestive evidence for linkage with single-p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b03ba9a8979950ed3fbffb18dc4942cd
http://www.scopus.com/inward/record.url?eid=2-s2.0-13444291029&partnerID=MN8TOARS